SCHEMBL267725

SCHEMBL267725

Cc1ccc(Cl)nc1NC(=O)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ADORA1 P30542 2/20 0.39
ATM Q13315 2/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 2/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
ABL1 P00519 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1661669 0.85 KMT2A (0.47) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL267717 0.83 L3MBTL1 (0.44) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL1047479 0.82 L3MBTL1 (0.43) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL3326127 0.82 L3MBTL1 (0.43) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL5374156 0.81 L3MBTL1 (0.42) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL12780025 0.81 L3MBTL1 (0.42) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL14999156 0.80 L3MBTL1 (0.44) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL25386662 0.80 L3MBTL1 (0.41) L3MBTL1HTTMEN1KMT2AADORA1
SCHEMBL30884722 0.80 PARP2 (0.45) L3MBTL1HTTMEN1KMT2AALDH1A1
SCHEMBL247107 0.80 L3MBTL1 (0.41) L3MBTL1HTTMEN1KMT2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134007-B2 Pyridine derivatives PFIZER INC. (US) 2012-03-13 US disclosed
US-20090048306-A1 PYRIDINE DERIVATIVES PFIZER, INC. (US) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048306-A1 PYRIDINE DERIVATIVES SDHA, P2RX4, P2RX3 L3MBTL1 4806/4885HTT 3191/4885MEN1 3487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.